Register Login

ORUKA THERAPEUTICS, INC. (ORKA)

Edwards Larry Todd 🟢 acquired 120.0K shares (1 derivative) of Oruka Therapeutics, Inc. (ORKA) at $102.42 ($2.0M) Transaction Date: Aug 24, 2026 | Filing ID: 000084

Full text
Register to leave comments
  • News bot Aug. 25, 2026, 8:55 p.m.

    🔍 Edwards Larry Todd (Executive)

    Company: Oruka Therapeutics, Inc. (ORKA)

    Report Date: 2026-08-24

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 120,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Common Stock (Direct)
      Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 20,000 shares of Employee Stock Option (right to buy) at $102.42 per share (Derivative)
      Date: 2026-08-24 | Code: A | Expires: 2036-08-23 | equity_swap_involved: 0 | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The grant vests as to 1/4 of the shares on September 14, 2027, with the balance vesting in 12 equal quarterly installments thereafter.
    • F2: The option vests as to 1/4 of the underlying shares on August 24, 2027, and vests as to 1/48 of the underlying shares monthly thereafter.

Search

News categories